Hayashi Lauren C, Benasi Giada, St-Onge Marie-Pierre, Aggarwal Brooke
College of Medicine, University of Florida, Gainesville, FL, USA.
Institute of Human Nutrition, College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
J Complement Integr Med. 2021 Dec 16;20(3):537-547. doi: 10.1515/jcim-2021-0294. eCollection 2023 Sep 1.
This brief narrative review aims to give an up-to-date overview of intuitive and mindful eating (I/ME) interventions with specific focus on cardiometabolic risk factors, including glucose, lipid profile, blood pressure and inflammatory markers.
I/ME intervention studies in adults which measured at least one physiological parameter other than weight were identified from PubMed. The clinical trial/randomized controlled trial filters and publication dates 2001 through April 2021 with variations of the following keywords were applied: intuitive eating, mindful eating, weight neutral. Ten articles were identified.
Of the 10 studies, seven showed I/ME interventions were more effective than control in at least one cardiometabolic outcome, two showed significant I/ME within-group improvements but no between-group differences, and one showed neither within-group nor between-group differences. Specifically, I/ME improved glucose levels among pregnant women with or without gestational diabetes, lipid profile among adults with overweight or obesity, blood pressure among participants with overweight and inflammatory markers among post-menopausal women with obesity. However, the positive impact of I/ME on each of these cardiometabolic parameters was not consistent across studies: of the six studies that examined glucose regulation, two demonstrated positive outcomes for I/ME group, whereas four found no effect compared to control. Three out of five studies had positive lipid effects, one out of five demonstrated systolic blood pressure (SBP) improvements and one of two showed improvements in inflammatory markers. Given these mixed results, more research is needed to understand the possible effectiveness of I/ME to improve cardiometabolic health.
本简要叙述性综述旨在提供关于直觉性饮食和正念饮食(I/ME)干预措施的最新概述,特别关注心脏代谢危险因素,包括血糖、血脂谱、血压和炎症标志物。
从PubMed中检索了针对成年人的I/ME干预研究,这些研究测量了至少一项除体重以外的生理参数。应用了临床试验/随机对照试验筛选器以及2001年至2021年4月期间使用以下关键词变体的文献:直觉性饮食、正念饮食、体重中性。共识别出10篇文章。
在这10项研究中,7项表明I/ME干预在至少一项心脏代谢结局方面比对照组更有效,2项显示I/ME组内有显著改善但组间无差异,1项显示组内和组间均无差异。具体而言,I/ME改善了患有或未患有妊娠期糖尿病的孕妇的血糖水平、超重或肥胖成年人的血脂谱、超重参与者的血压以及肥胖绝经后女性的炎症标志物。然而,I/ME对这些心脏代谢参数中每一项的积极影响在各研究中并不一致:在6项研究葡萄糖调节的研究中,2项显示I/ME组有积极结果,而4项发现与对照组相比无效果。5项研究中有3项对血脂有积极影响,5项中有1项显示收缩压(SBP)有所改善,2项中有1项显示炎症标志物有所改善。鉴于这些混合结果,需要更多研究来了解I/ME改善心脏代谢健康的可能有效性。